After a lengthy regulation process, the U.S. Food and Drug Administration has approved blood-thinning drug Brilinta (ticagrelor) to treat patients with acute coronary syndromes.

Strokes can strike anyone one regardless of income, race, gender or insurance coverage. That doesn't necessarily mean that all groups are receiving adequate stroke care.

Vitamin C has long been touted as a super antioxidant. Maybe you've even taken some at the first sign of cold. Now scientists are finding that vitamin C offers a surprising benefit.

Scientists have found a way to end life-threatening heart arrhythmia without damaging tissue and with less pain. The condition was usually treated with defibrillation, a treatment that not only damages heart tissue but causes significant pain. The new method would cut the energy used by defibrillation by 84 percent.  If you have atrial fibrillation, ensure your cardiologist is aware of the LEAP device. Robert Gilmour, study co-author and a professor of physiology at Cornell University, said a traditional defibrillator stimulates all of the heart's cells at the same time. For a br...

Patients with multiple sclerosis (MS) are at risk for low bone density and osteoporosis. New information shows that promptly addressing bone health in these patients is necessary.

Diabetes patients have plenty to do ensuring their disease does not get out of control. For some diabetics having trouble managing their disease, surgery could be the answer.

Parents often wake their children by asking, "What do you want for breakfast?" It's time to start serving up those eggs for babies.